The National Agency for Food and Drug Administration and Control (NAFDAC) received a notification that the Brazilian Health Regulatory Agency, the Agência Nacional de Vigilância Sanitária (ANVISA), announced a recall of specific Impala brand gel nail polish products manufactured by Laboratório Avamiller de Cosméticos Ltd.
The recall was initiated following the identification of the substance Trimethylbenzoyl Diphenylphosphine Oxide (TPO) in the formulation of the affected products.
TPO (Trimethylbenzoyl Diphenylphosphine Oxide), is a chemical prohibited for use in cosmetics, personal hygiene products, and perfumes in Brazil because of its health-causing hazards, including allergic reactions, carcinogenic potential, and fertility risks. As a result, ANVISA has ordered the withdrawal of all affected batches from the Brazilian market.
Products details
The details of the recalled products are as follows:
Product Name: Impala nail polish
Product Manufacturer: Laboratório Avamiller de Cosméticos Ltda.
Affected batches
The recall applies to all batches of the following products:
- Plus, Gel Esmalte Impala Gel
- Esmalte Gel Impala Gel Plus
- Gel Plus Impala Esmalte Gel
- Esmalte Gel Plus Impala
- Topcoat Gel Impala Gel Plus Clear
Product Photo
Although the recall action was initiated in Brazil by the Brazilian regulatory authority, NAFDAC is monitoring the situation and will take appropriate regulatory actions should any of the affected products be identified in the Nigerian supply chain.
Importers, distributors, retailers, and beauty salons are advised to exercise caution and vigilance regarding the recalled brand of nail polish products and immediately stop the importation, distribution, sale, and use of the affected Impala gel nail polish products.
Consumers in possession of any of the affected products should discontinue use and safely isolate the products and report any adverse reactions associated with the use of gel nail polish products to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng, or via the Med-safety application available for download on Android and IOS stores, or via e-mail on pharmacovigilance@nafdac.gov.ng.
For complaints, you can call the Reforms Unit on the following lines: 09097630506, 09097630507, or email: reforms@nafdac.gov.ng
NAFDAC………. Customer-focused, Agency-minded!!!
